My Mobile Advice Program: A Randomized Pilot Feasibility Study

• Status: Completed
• Trial end date: 2016-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this pilot study is to evaluate the acceptability and feasibility of the proposed smoking cessation intervention (called MyMAP or My Mobile Advice Program).

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Group Health Cooperative; Kaiser Permanente
• Collaborators: University of California, Davis; University of Michigan
• Treatments: Nicotine; Varenicline

Criteria

Inclusion Criteria:

• An invited member of Group Health, a health care system in the Pacific Northwest

• Plan to remain enrolled in Group Health for the next 6 months

• aged 18 - 65

• Eligible for smoking cessation treatment through Group Health insurance coverage

• smoke >= 10 cigs a day

• speak and read in English

• willing to use varenicline and no contraindications for this medication

• ready to quit smoking

• have a smart phone with internet access

• willing to receive study texts and emails

• receive care at a Group Health clinic and have electronic medical records in this system

• fill prescriptions through the Group Health pharmacy

• agree to use birth control while taking study medication, if there is a risk of pregnancy

Exclusion Criteria:

• lifetime history of dementia

• psychosis or bipolar disorder based on self-report or medical record review

• hearing, comprehension or visual limitations that preclude full study participation

• current use of other forms of tobacco

• any medical contraindication for varenicline use

• documented history of suicidal ideation/intent